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ABSTRACT
ANTIOXIDANT GENE POLYMORPHISMS AND SUSCEPTIBILITY TO SOLVENTINDUCED HEARING LOSS IN FACTORY WORKERS.
Robert U. Glazier, Peter M. Rabinowitz, and Martin D. Slade. Department of
Occupational and Environmental Health, Yale University, School of Medicine, New
Haven, CT.
Occupational exposure-related hearing loss is a significant health concern for affected
workers. Organic solvent exposure has emerged as an important contributor to hearing
loss. It is thought that hearing loss related to solvent and noise exposure is mediated by
reactive oxygen species (ROS). The glutathione associated enzymes and the manganese
superoxide dismutase enzymes (SOD2) are important components of the cochlear hair
cell’s defense against oxidative stress. This study is aimed to determine whether
polymorphisms within the glutathione S-transferases (GST) P1 and GSTM1, glutathione
peroxidase 1 (GPX1), and SOD2 are associated with hearing status in solvent exposed
factory workers. Genotypes for the GSTM1 + vs. null, GSTP1 Ile105Val, GPX1
Pro198Leu, SOD2 Val16Ala polymorphisms along with hearing status were determined
in factory workers exposed to organic solvents. Hearing tests consisted of pure tone
audiometric (PTA) thresholds from 3-6 kHz and distortion product otoacoustic emissions
(DPOAEs) for 3-6 kHz. Bivariate and multivariate regression analysis was undertaken
to assess for association between polymorphisms and hearing outcomes. The GSTP1
Val/Ile genotype at position 105 was associated with higher PTA thresholds (β=12.41, P
value= 0.01) from 3-6 kHz in workers below age 22-43. The analysis showed a protective
association of the SOD2 Ala/Val genotype (β= -26.42, P value= 0.025) and The GPX1

Leu/Leu genotypes (β=47.81, P value= 0.034) with audiometric thresholds from 3-6 kHz
in individuals above age 43. This small cross-sectional study suggests that
polymorphisms within the antioxidant system may alter susceptibility to hearing loss in
workers exposed to organic solvents. These results also suggest the mechanisms by
which this affect are mediated are complex and should be further investigated.
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INTRODUCTION
Sensorineural Hearing Loss as Public Health Issue
It is reported that 28 million Americans suffer from sensorineural hearing loss1.
Similarly, worldwide hearing impairment is reported to affect more than 10 percent of the
adult population of industrialized nations2. Beyond the difficulty of day-to-day living for
sufferers, hearing impairment carries with it significant socioeconomic implications for
the afflicted and significant costs to national economies. Studies show that the hearingimpaired are much less likely to be employed and earn less than their normal-hearing
counterparts3. The economic impact of hearing impairment represents a significant
portion of the 156 to 187 billion dollars spent in the United States annually on
communication disorders3.

Mechanisms of Sensorineural Hearing Loss
It is also reported that at least 10 million of those suffering hearing deficits may be
affected due to elevated noise exposure of an occupational or recreational origin1. There
is a growing body of evidence that suggests that multiple environmental and genetic
factors may play a role in the development of sensorineural hearing loss. Along with
noise exposure within the occupational setting, chemical exposure to organic solvents has
emerged as an important suspected cause of clinically significant hearing loss4.
Both solvents and noise are thought to mediate hearing loss by the generation of reactive
oxygen species (ROS)5, 6. In the process of sound transduction, the stria vascularis must
continually maintain an electrochemical gradient between the endolymph and the outer
hair cells via ion pumps; maintenance of this gradient and the tuning of the basilar
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membrane by the outer hair cells are energy demanding processes7. Normal aerobic
metabolism results in the generation of the highly reactive superoxide anion radical and
subsequent derived reactive oxygen species. The ROS generated under levels subpathologic sound stimulation are normally adequately handled by the cells’ natural
antioxidant system8, 9 (see Brief Review of Radical Generation and Handling below).
However, when noise intensity reaches pathologic levels, acoustic overstimulation leads
to an imbalance between ROS generation and handling resulting in a disruption of
cochlear homeostasis. As described by Kopke et al., initial increases in sound are met
with an increase in uptake of glucose and in cochlear tissues and a 20% increase in
perilymphatic oxygenation. Further increase in sound leads to an unexpected decrease in
endolymph oxygenation, cochlear blood flow, and glucose uptake6. This described
radical generation and decrease in circulation was observed by Yamane et al. in 1999
when guinea pigs were exposed to 3 hours of “rock-n’-roll” music at 120-125 dB sound
pressure level (SPL); elevated superoxide levels in the marginal cells, and empty
capillaries within the stria vascularis were observed at 5 minutes post-exposure10.

Direct cellular damage and ROS generation in noise exposed outer hair cells were first
observed and reported in 199911. Nicotera et al. utilized dichlorofluorescein (which
stains for reactive oxygen species and/or the peroxynitrite radical (ONOO-)) and found
evidence of elevated ROS in the nuclear region of the outer hair of chinchillas exposed to
impulse and continuous noise11. Furthermore, staining of these noise exposed chinchilla
cochleae with propidium iodine and acridine orange revealed hair cell death by apoptosis
and necrosis11. Evidence for the observed ROS as a cause, rather than the result, of
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cellular damage emerged in 199612 and 200513. When superoxide generating compounds
were infused into the perilymph it led to a decrease in the compound action potential
sensitivity (a measure of physiologic response to sound) 12 , permanent threshold shifts
(PTS) 13, and outer hair cell death13.

Organic Solvents and Hearing Loss
Within the realm of hearing conservation programs in the industrial setting, noise has
been the primary exposure of concern. Evidence in recent decades has led to the
identification of neurotoxic agents commonly encountered in many workplaces that may
be contributing to occupational hearing loss14. Organic solvents are but one class of these
agents common in many workplaces that have proved ototoxic in animal and human
studies and have been the subject of focused investigation15-23.
Pryor et al. and Rebert et al. first reported of an association between solvent exposure and
hearing loss in animals in 198315, 23. A review of previous case reports and a case series
of Scandinavian workers who were exposed to noise and solvents with hearing thresholds
much worse than would have been predicted by noise exposure alone was published by
Barregard and Axelsson in 198424. In 1986, a 20-year longitudinal study of 319 workers
in a Swedish timber processing factory was published by Bergstrom and Nystrom25.
When the workers in the chemical department of the company who were exposed to
lower levels of noise (80-90dBA) were compared to workers outside the chemical
department where noise exposure was higher (95-100dBA), it was discovered that 23%
of chemical workers demonstrated pronounced hearing loss while 5-13% of workers from
areas outside the chemical area of the plant exhibited hearing loss.
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Subsequently, the direct ototoxic effects of solvents in animals and humans have been
well confirmed14, 16-20, 22, 26-30. Most recently, Fuente et al. reported a negative effect of
solvent exposure on measured pure tone audiometric thresholds in factory workers31.
In addition to these studies that have shown organic solvents experimentally to be
ototoxic alone, there is some evidence solvents may synergistically interact with noise to
potentiate sensorineural hearing loss32-41; this relationship is significant as many
workplaces in which there are noise levels warranting a hearing conservation program
also expose workers to potentially ototoxic levels of solvents. It has also been suggested
that solvent exposure and concomitant noise exposure may be an unrecognized risk, even
when exposure levels are below standards set by the Occupational Safety and Health
Administration (OSHA) and American Conference of Governmental Industrial
Hygienists (ACGIH)42.

Organic Solvents and Reactive Oxygen Species
The full extent of the mechanisms by which solvents induced cochlear pathology is an
area of active investigation. Importantly, there is evidence that some organic solvents
can contribute to oxidative stress and may potentiate the effects of noise on hearing in
this way43-47. The organic solvents to which the workers in our study population are
exposed in this study are: methyl ethyl ketone (MEK), toluene, and xylene. McDermott
et al. demonstrated that cells in culture exposed to MEK, toluene, and xylene have
increased levels of membrane permeability, decreased reduced glutathione levels, and
increased levels of cytosolic Ca++43; these changes likely represent increased ROS
burden. In vitro experiments of hair cells show a similar increase in intracellular free
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Ca2+ when the cultures were exposed to acoustic trauma and mechanical disruption
designed to mimic noise48, 49. There are several examples of Ca2+ mediated downstream
effects of oxidative stress50. ROS have been shown to increase the levels of intracellular
Ca2+ by interfering with the proteins responsible for Ca2+ transport out of the cell50.
Alternatively, increased free cytosolic Ca2+ has been shown to increase ROS levels in
cells expressing xanthine reductase50. Rising Ca2+ activates calpain enzymes that convert
xanthine reductase into xanthine oxidase, which in turn generates O 2- radicals50.
Animal model studies have yielded similar increases in intracellular free Ca2+
concentration in rat cochlea hair cells when exposed to levels of toluene similar to those
expected in workers exposed at or below recommended occupational limits51, 52. In rat
studies, Mattia et al. reported an elevation of ROS in the livers and central nervous
system46, 47 in animals exposed to toluene; xylene exposure led to reduced levels of
hepatic reduced GSH53.
Evidence of solvent-induced oxidative stress in humans is reported by Halifeoglu et al.;
workers exposed to paint thinner (containing toluene) showed increased plasma
malondialdehyde (a marker of lipid peroxidation) and elevated GPX and SOD enzyme
levels compared to contols44. The suggested implication of the effect of ROS generated
by these solvents is bolstered by the fact that toluene and xylene have exhibited direct
ototoxicity in several animal studies16, 17, 26, 30, 54, 55 and that ROS in cochlear tissues have
been repeatedly been shown to affect hearing12, 56.
While the delivery route of these organic solvents has not been definitively proven,
Campo et al. showed that rats treated with toluene via inhalation had toluene
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contaminated organs of Corti, suggesting direct tissue toxicity19. Taken with the fact that
the outer hair cells are the most susceptible to solvent-induced injury, these results point
to a hematogenous route of intoxication from the stria vascularis via the outer sulcus and
lipid rich membranes composed of Hensen’s cells and Dieters cells, onto the outer hair
cells19.

Brief Review of Radical Formation and Handling
The cellular antioxidant system is composed of numerous enzymes and substrates which
act to catalyze the detoxification and conjugation of ROS. Within the cochlear tissues,
animal studies have identified the presence of two major pathways composed of three
classes of antioxidant system enzymes: The superoxide dismutase (SOD) and catalase
enzymes6 and the glutathione (GSH) related enzymes57, 58.
Superoxide (O2-) is generated by the reduction of oxygen in aerobic respiration and other
normal cellular reactions (e.g. xanthine oxidase action). The superoxide dismutase
(SOD) family of antioxidant enzymes convert the generated superoxide anion into H2O2
and O2 (202- + 2 H → H2O2 + O2)50. Site specific haplotypes of SOD reside and function
within the mitochondria, cytoplasm, and extracellular space that serve this function only
within their respective compartments: manganese SOD (MnSOD or SOD2) in the
mitochondria, copper/zinc SOD (CuZnSOD or SOD1) in the cytoplasm, and extracellular
SOD (ECSOD or SOD3)59. The catalase (CAT) enzymes present in cellular peroxisomes
act to convert the H2O2 generated by SOD into O2 and H2O (2H2O2 → O2 + H2O)50.

13

Reactions of unreduced generated superoxide and intermediate ROS such as H2O2 with
susceptible cellular molecules also occur that initiate self perpetuating free radical
damage to cellular structures such as peroxidation of membrane lipids. This oxidative
stress has detrimental effects on energy production and membrane permeability as well as
downstream signaling events that can initiate programmed cell death.
The glutathione peroxidases (GPX) are a class of selenium dependant enzymes which
catalyze the breakdown of H2O2 by reduction and the formation of conjugated glutathione
(GSSG) from reduced glutathione (GSH) (H202 + 2GSH → GSSG + 2H2O)60. The
ubiquitously expressed glutathione peroxidase 1 (GPX1) has a single selenocysteine
residue on each of its four identical subunits and is one of the most important antioxidant
enzymes in humans.
Glutathione-S-transferase (GST) enzymes catalyze the conjugation of electrophilic
radicals to the sulfhydryl residues of reduced glutathione (GSH + Xradical → GSradical
+HX) 61 enzymes, thus neutralizing free radical species and halting free radical chain
reaction damage. These radicals include endogenous species as well as xenobiotic
molecules.62 Epoxides, activated alkenals, and organic hydroperoxides that result from
oxidative metabolism are regarded as the major “natural” substrates of the GST. 62

Solvents, Reactive Oxygen Species, and Genetic Polymorphisms
With the available evidence that noise-induced and the likelihood that solvent-induced
hearing loss are both mediated by ROS, it would follow that the cellular antioxidant
molecules would play an important role in modifying the effects of noise and solvents in
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cochlear pathology. The antioxidant enzymes GST, GPX, and SOD all play a role in the
detoxification of ROS. Indeed animal studies have shown that knockout mice expressing
GPX1-/-63 and SOD1-/-64 were more susceptible to noise-induced hearing loss (NIHL)
than wild type controls. In the studies of toluene cited above there was also an observed
decrease of GSSH in tissues showing increased ROS46. A similar decrease in
GSSH/GSSG was observed in in vitro assays of cells treated with MEK, toluene, and
xylene43. Depending on the mechanisms of solvent detoxification, activation, and
conjugation, a gain or loss of function in enzymes catalyzing these steps could lead to
elevated or diminished toxicity. Studies have shown that genetic polymorphisms in
genes responsible for solvent metabolism, ROS generation, and antioxidant function can
modify risk for developing chronic solvent encephalopathy (CSE)65. Genetic
polymorphisms for CYP2E1, EPHX1, and GSTP1 modified risk of developing CSE in
organic solvent-exposed workers when compared to non-exposed controls65. A similar
study showed that GSTM1 null individuals that smoked tobacco were at an elevated risk
for CSE; this elevated risk was not seen among non-smoking GTSM1 null individuals66.

SOD2 and Sensorineural Hearing Loss
Much of the previous investigation into superoxide handling and hearing status has
centered on the cytosolic SOD1. SOD1 has been shown in several animal studies to be
associated with noise- and age-related hearing loss64, 67-69. Studies in which targeted
deletions of SOD1 have been performed in mice have shown an increased susceptibility
to presbycusis68, 69 and noise-induced hearing loss64 in SOD1 knockouts. While
deficiency of SOD1 predisposes to hearing loss, studies have shown that over-expression
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has little or no protective effect against age- and noise-induced hearing loss69, 70.
Interestingly, one study in which transgenic C57BL/6-TgN_SOD1_3Cje mice overexpressing SOD1 were compared to non transgenic C57BL/6-TgN_SOD1_3Cje
littermates showed no difference in auditory brainstem responses (ABR) after noise
exposure. Cohorts of the same SOD1 normal and SOD1 over-expressing mice did not
show any difference in ABR when aged 2-7months. However, the transgenic mice did
show an increase in mitochondrial DNA-deletion levels (a marker for age-related
damage) in acoustic nerve tissue; this led Coling et al. to suggest the role of SOD1 in
ROS homeostasis may be more complex than previously appreciated or presumed. 70

The SOD2 Val16Ala Single Nucleotide Polymorphism
As noted previously, SOD2 catalyzes the reduction of superoxide within the
mitochondrion. The SOD2 enzyme is a homotetramer of identical subunits, each of
which are encoded on chromosome 6q25. The gene encodes a 222 amino acid
polypeptide of which the first 24 amino acids encode a mitochondrial targeting
sequence71, 72. There are relatively few polymorphisms in the SOD2 gene, this is likely
due to SOD2 occupying a critical role in the prevention of cellular oxidative damage73.
One notable, and the most studied, SOD2 single nucleotide polymorphism (SNP) is the
Val16Ala variant that occurs when T transitions to a C in base 47 within the
mitochondrial signaling domain74. Compared to the Val genotype, more active SOD2 is
translated from the Ala expressing alleles and these variants have been shown to be more
efficiently transported into the mitochondrial matrix which may lead to higher levels of
functional SOD2 in the mitochondria75-77. Interestingly, studies of both variant alleles
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have suggested individual association with differing pathologies. The homozygous Val
variant has been shown to be associated with non-familial idiopathic cardiomyopathy75
and non-small cell lung carcinoma78. The Ala variant has been associated with motor
neuron disease79, Parkinson’s disease74, 80, increased shrinkage of grey matter in
alcoholics81, urolithiasis82 breast cancer83, 84, longevity85, and prostate cancer 86.

GSTM1 and GSTP1 GPX1 Polymorphisms
Glutathione S-transferase P1 and M1 (GSTP1 and GSTPM1) have higher measured
activities in the cochlea than in other sensorineural tissue57. It is possible that this high
activity is an indication of the importance of their role in controlling oxidative damage in
the cochlear tissues. It is reported that between 40-60% of the population lacks a
functional copy of the GSTM1 gene87-89. This GSTM1 null genotype has been associated
with elevated risk of lung cancer90, 91, breast cancer (given alcohol consumption)92, and
colorectal cancer93. The GSTP1 Ile105Val polymorphism has been reported to affect the
enzyme’s substrate affinity and heat stability94. This variant also demonstrates increased
catalytic efficiency with aromatic epoxides95 and is reported to elevate risk for testicular
and bladder cancer96.
Glutathione peroxidase 1 (GPX1) is ubiquitously expressed in human cells and is
elevated in metabolically active tissues. The Pro198Leu variant of GPX1 is not reported
to have any diminished enzymatic activity97 but has been identified with risk for lung98
and breast99 cancer as well as selenium deficiency, Keshan disease100, thoracic aortic
aneurism101, prostate cancer (decreased risk in heterozygotes) 102, metabolic syndrome in
Japanese men103, hypertension104, bladder cancer recurrance105, and longevity85.
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Statement of Purpose of Specific Hypothesis and Specific Aims of the
Thesis
The evidence for the role of ROS in the development of solvent-induced hearing loss
(SIHL) begs the question whether such a relationship could be modified by genetic
antioxidant factors as it has been demonstrated in NIHL. Identification of defined
antioxidant genetic polymorphisms as risk factors for the development of SIHL would
serve to support the reasoning that SIHL is mediated through ROS. Evidence of this type
could also serve as an important tool in tailoring prevention strategies against SIHL in
susceptible individuals.
To our knowledge, no study has been published to assess the effect that antioxidant gene
polymorphisms may have in the development of sensorineural hearing loss in workers
exposed to solvents. It is our hypothesis that polymorphisms of GSTM1, GPX1, GSTP1,
and SOD2 in which functional studies have shown a change in activity or expression will
be associated with hearing status in factory workers exposed to ototoxic solvents. We
aim to detect any association by statistical analysis controlling for known hearing loss
associated variables. We also aim to investigate the relationship between antioxidant gene
polymorphisms and solvent-induced hearing loss to test if the ROS mediated mechanism
of SIHL is supported by our analysis.

METHODS
This study was designed as a cross-sectional pilot study. A total of 93 (11 female and 82
male) industrial workers were recruited for the purposes of the study. All of the
participants were employed full time at a factory that produced large rolls of
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polyurethane coated fabric. The polyurethane is applied in a liquid form onto wide rolls
of synthetic fiber fabrics. Workers from every work area were invited to participate as
subjects in the study. Though workers from all areas in the factory participated, the
majority of the workers at the plant that enrolled were production laborers.
Information detailing the purpose of the study as well as the nature of the study protocols
was given to the participants in both written and oral form. Informed consent was
obtained from all participants in keeping with the guidelines of the study protocol
approved by the Yale Human Investigation committee. All subjects were assigned an
anonymous numerical identifier and the coded key with subject’s names was kept in a
password-protected file on a network isolated computer in a locked room.
Genetic analysis was performed by Dr. Adam Wisnewski and members of his laboratory.
Samples of whole blood were collected in yellow top acid-citrate-dextrose tubes. DNA
was extracted and purified from 200 µl of whole blood using a commercial kit from
Qiagen®. PCR was used to amplify all desired gene segments and products
electrophoresed against a base pair standard in 3% agarose gels with ethidium bromide.

GTSM1 Analysis
A direct PCR was used to determine the presence (or absence) of the GSTM1 gene. The
following 3 primers were used to simultaneously amplify GSTM1 and GSTM4 (as an
internal positive control). GSTM1 5’-CGC CAT CTT GTG CTA CAT TGC CCG-3’ 5’ATC TTC TCC TCT TCT GTC TC-3’ 5’- TTC TGG ATT GTA GCA GAT CA -3’.
Amplification results in the following bands: 158bp band for GSTM4, and a 231bp band
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for GSTM1, if present. PCR mixture consisted of: 20 mM Tris-HCl (pH 8.4), 50 mM
KCl, 1.0 mM MgCl2, 0.2 mM dNTPs, 0.3 pM of each primer, 200-400 ng gDNA, 1.25 U
Taq. Polymerase. PCR cycling conditions were 94°C 2min, (94°C 1min + 72°C 1min) ×
30cycles, 72°C 7min.

GSTP1 Analysis
Identification of SNP at amino acid 105 which results in the replacement of the isoleucine
with a valine was accomplished as described by Lin et al 106. The primers 5’- GTA GTT
TGC CCA AGG TCA AG -3’ 5’- AGC CAC CTG AGG GGT AAG -3’ and the same
PCR mixture composition were used to amplify a 433bp band that was digested with 5U
Alw 26I and run on a 3% agarose gel. The “wild type” allele (GSTP1 +/+) has one
restriction cut site and yields a 329bp band and a 104bp band. On digestion, the
polymorphic (null) allele (GSTP1 -/-) yields bands of 222bp, 107bp, and 104bp in length.
Heterozygotes (GSTM +/-) showed all 4 bands: 329bp, 222bp, 107bp, and 104bp. PCR
reagent composition were the same as for GSTM1. PCR cycling conditions: 94°C 2min,
(94°C 1min + 72°C 1min) × 30cycles, 72°C 7min.

GPX-1 Analysis
The GPX SNP at codon 198 which changes a proline to leucine was detected using
methods described by Hu et al99. The PCR primers 5’- TGT GCC CCT ACG CAG GTA
CA -3’ 5’- CCA AAT GAC AAT GAC ACA GG -3’ flank the polymorphic region and
yield a product of 337bp. The polymorphic leucine at codon 198 creates a site cleavable
by Apa 1 restriction enzyme. Upon Digestion of DNA by Apa 1, homozygous wild type
(GPX1 +/+) yield the single 337bp band. Homozygous polymorphic alleles (GPX -/-)
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yield two bands at 79bp and 258bp. Heterozygous samples (GPX +/-) show all 3 bands:
79bp 258bp and 337bp. PCR reagent mixture was identical to that used in GSTM1 and
GSTP1. PCR cycling conditions: 94°C 3min, (94°C 0.5min + +58°C 1min + 72°C
1.5min) × 35cycles, 72°C 10min.

SOD2 Analysis
Identification of the Val-16-Ala SNP (a T to C transition in the mitochondrial signaling
domain) was effected by the methods previously described by Lin et al106. The primers
used were: 5’- GCA CCA GCA GGC AGC TGG CGC CGG-3’ and 5’- TGC GCG TTG
ATG TGA GGT TCC AG -3’. A single base pair mismatch was introduced into the
forward primer to create a Nae 1 site in the Alanine coding allele. The PCR products
were purified through use of a PCR clean-up column to remove primer dimmers, and
then digested with 5U Nae 1. The homozygous Val allele (SOD2 -/-) shows a band at
112bp. The heterzygotes (SOD2 +/-) show 3 bands at 112bp, 90bp, and 22bp.
Homozygous Ala individuals (SOD2 +/+) only show 2 bands at 90bp and 22bp.

Hearing Tests
Data was collected in the form of a hearing test battery designed to measure several parts
of the auditory system. All audiometric tests were performed by certified audiologists
Frank Nusdeu and Adrian Fuente. An otoscopic exam and tympanometry test was
performed to ensure the absence of external ear obstruction such as cerumen impaction
and/or other middle or external ear pathology. Tympanometry was measured by a GSI
37 auto-tympanometry middle ear analyzer. Subjects were required to have type A
results bilaterally107. Subjects with abnormal otoscopy, or tympanometric results falling
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outside said parameters, were eliminated from the study. The rest of the test battery
consisted of conventional pure tone audiometry (PTA) (from 500-8000Hz), very high
frequency PTA (12 and 16 kHz), dichotic digits test, and distortion product otoacoustic
emissions (DPOAEs)(from 2000-8000 Hz). The DPOAE, and PTA tests were conducted
in an Acoustic Systems® double walled sound booth to effectively eliminate ambient
noise. Air conduction PTA thresholds from 500 Hz to 8000 Hz, and high frequency PTA
thresholds, at 12 and 16 kHz, were measured with an Interacoustics® AC40 clinical
audiometer. Telephonics® TDH-39P headphones were used for conventional PTA
thresholds (500-8000 Hz) and Koss® R/80 headphones for high-frequency PTA
thresholds. DPOAEs were measured utilizing Madsen Capella equipment connected to a
Dell notebook computer. DPOAEs were tested as follows: two continuous tones were
presented monaurally to each ear at differing frequencies designated f1 and f2, the ratio
of frequencies was maintained at f2/f1=1.22. The tone at f2 was 10 dB lower than the
tone at f1. The primary tone f2 was presented at 5 frequencies (2-8 kHz). The 2f1-f2
DPOAEs levels and corresponding measured noise floor were registered as a product of
f2. DPOAE amplitudes measuring 3 dB or more above the noise floor were considered a
response. All tests were performed by a certified audiologist at the facilities of
Occupational and Environmental Medicine Program, Yale University.

Exposure Assessment
Written bilingual (English and Spanish) questionnaires were given to the participants
prior to audiometric testing to assess self-reported noise and solvent exposures.
Preparation and administration of these questionnaires was performed by the Department
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of Occupational and Environmental Medicine at Yale University School of Medicine.
Exposure data was collected for current and prior employment as well as relevant
recreational and military activities. Questions relating to pertinent medical and social
history, along with other known risk factors for hearing loss were also included.
Measurements of previous environmental solvents (toluene) were obtained from the
factory records. Air samples for solvents have been taken by using charcoal tube and
personal sampling pumps. Collection was undertaken around areas occupied by workers,
including the quality control laboratory, the machines processing polyurethane coated
fabrics, and the mixing shed. Conventional air sampling techniques were used to collect
samples (NIOSH Sampling and Analytical Methods). Air sample analysis was
accomplished by gas chromatography-flame ionization detection. The recorded
concentrations ranged between 0.1 ppm and 26 ppm (average concentration for the nine
workstations sampled was 4.71 ppm).
This factory was chosen because of known solvent use among the production laborers.
Noise exposures at this site had not been measured at levels that would require a hearing
conservation program (85 >dBA, time weighted average for 8 hrs)108. To best control
for any effect of noise on hearing status, noise exposure indices were calculated based on
a workers self reported level of ear protection use during noise exposure from previous
and current employment as well as recreational noise exposure.
Solvent exposure was assessed by the workers’ self-report of contact with solvents along
with the self-report of episodes of symptomatic acute solvent intoxication. Additionally,
an experienced industrial hygienist familiar with the plant assigned a solvent exposure
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number to each participant based on job title and work area. Workers that had worked in
multiple areas of different solvent levels were assigned a group using a time weighted
average of exposure duration. The numbers ranged from 1-3 with 1 being the least
exposed. This number was multiplied by the number of years the subject had been
working at the factory to create an exposure index product for the exposure limited to the
factory site.
A total of 94 subjects were recruited for the study. One individual had abnormal
tympanometric test results and could not be included; 93 were used for the analysis.

Statistical Analysis
Genetic test results were linked by the author with questionnaire and hearing test data
from medical charts into a computer database by anonymous numerical identifiers.
Statistical analysis was performed using SAS 9.1 statistical software package (SAS
Institute, Cary, NC, USA). Binaural averages were calculated for DPOAEs and PTA
thresholds (high frequency and very high frequency) and dichotic digits. Combined
binaural DPOAEs averages for frequencies 3000, 4000, and 6000 Hz were calculated for
each subject. A binaural average of PTA thresholds at 3000, 4000, 6000 Hz was also
calculated for each subject. Linear regression was performed to determine the association
between hearing status and the predictors.
Initially, bivariate analyses were conducted separately for each of the above listed
hearing outcomes with the following variables: age, race, eye color, solvent group,
solvent group index, recreational noise exposure, years at factory, experienced acute
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solvent intoxication, cigarette use (pack-years), alcohol use (average drinks/week
multiplied by years), outside of work solvent exposure index, and genotypes for GSTM1,
GSTP1, GPX1, and SOD2.
Table 1. Variables used in model construction.
Variable
GSTM1
GSTP1

SOD2

GPX1

Eye Color

Hair Color

Race

Ethnicity
Age (years)
Solvent Group

Years at Factory
Years × Solvent Group Index
Cigarettes Use Years
Cigarette Pack × Year
Alcoholic Drinks per Week × Years
Recreational Noise Exposure Index
Noise Exposure Index
Acute Solvent Intoxication

Categorical
Present (+)
Null (-)
Ile/Ile (+/+)
Ile/Val (+/-)
Val/Val (-/-)
Ala/Ala (+/+)
Ala/Val (+/-)
Val/Val (-/-)
Pro/Pro (+/+)
Pro/Leu (+/-)
Leu/Leu (-/-)
Brown
Blue
Green
Other
Brown
Black
Blond
Auburn
Black
White
Pacific Islander
Asian
Native American
Hispanic
Non-Hispanic

Continuous Range

22-67
1 Least Exposed
2 Medium Exposed
3 Most Exposed
0-31
0-90
0-49
0-49
0-500
0-450
0-175
Yes
No
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Next, a set of four multivariate models were analyzed for each of the outcomes. To
better control for age and to explore the effect of ethnicity additional models were
constructed. In total the logistic models for each outcome were composed of: entire data
set, age stratified data set (age: 22-43yrs, 44-67yrs), Hispanics only and age stratified
Hispanics (age: 22-43yrs, 44-67yrs) for each of the hearing outcomes. Initial model
speculation included variables that have been reported or are suspected to have an impact
on hearing status. These variables are summarized in table 1. A backward elimination
strategy was employed using a significance level-to-stay of p = 0.05.

RESULTS
Pure Tone Audiometry Thresholds
Table 2 summarizes the outcomes for the included variables for both bivariate and age
stratified multivariate analysis. In the multivariate model for subjects 43 years and
younger, a significant association between SOD2 genotype and high frequency (3,4,6
kHz) audiometric threshold value is observed. The homozygous valine at position 16
genotype is associated with lower thresholds measured with high frequency pure tone
audiometry with a β of -20.11 and p-value of 0.023. In the same model, a significant
protective association of the heterozygous SOD2 genotype (Val/Ala) with high frequency
(3,4,6 kHz) pure tone audiometric thresholds was also observed with β value of -16.51
and p-value of 0.009.
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Table 2. Cohort variables correlation with pure tone audiometric thresholds binaural average at 3,4,6 kHz
Bivariate Analysis
All Ages

Variable

GSTM1 (null) (reference)
GSTM1 (present)
GSTP1 -/- (Val/Val)
GSTP1 +/- (Val/Ile)
GSTP1 +/+ (Ile/Ile)
(reference)
GPX1 -/- (Leu/Leu)
GPX1 +/- (Pro/Leu)
GPX1 +/+ (Pro/Pro)
(reference)
SOD2 -/- (Val/Val)
SOD2 +/- (Ala/Val)
SOD2 +/+ (Ala/Ala)
(reference)
Age
Hispanic
Non-Hispanic
White (reference)
Black
Asian
Native American
Years at Factory
Alcoholic Drinks per
Week×Yrs.
Cigarette Pack×Years
Noise Exposure Index
Recreational noise protection
Solvent Exposure Group
Years × Solvent Exposure
Group
Acute Solvent Intoxication
Hair Color Black (reference)
Hair Color Blond
Hair Color Auburn
Hair Color Brown
Eye Color Brown (reference)
Eye Color Blue
Eye Color Green
Eye Color Other

Multivariate Models

β

P value

1.1

0.80

-7.36
-4.2

0.25
0.37

-16.19
-10.0

0.02
0.01

1.9
-0.94

0.7
0.85

1.06
6.6

<.0001
.12

-9.6
-17.7
-14.1
0.81
0.04

0.15
0.09
0.43
0.006
0.02

0.04
0.10
0.02
4.86
0.30

0.84
0.07
0.51
0.046
0.004

-2.49

0.71

-1.4
-3.7
3.1

0.94
0.62
0.66

-4.0
7.11
-1.4

0.5
0.42
0.86

Age ≤ 43

All Ages
β

P value

β

P value

0.62
12.41

-20.11
-16.51

1.02

5.03

>0.0001

0.012

43 < Age

0.91

β

P value

0.91
0.01

0.023
0.009

-47.81
-8.22

0.034
0.24

-18.95
-26.42

0.15
0.025

0.012

-37.33
-3.15

0.0037
0.74

23.64
59.62

0.31
0.026

-2.72
-0.09

0.0055
0.032

8.52
0.098

0.005
0.002

0.31

0.018
47.13
-2.61

0.003
0.010

72.0
23.5
-3.42

0.006
0.041
0.78
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Table 3. Cohort variables correlation with DPOAEs, Binaural Average at 3,4,6 kHz
Bivariate Analysis
All Ages

Variable

GSTM1 (null)
GSTM1 (present)
GSTP1 -/- (Val/Val)
GSTP1 +/- (Val/Ile)
GSTP1 +/+ (Ile/Ile)
(reference)
GPX1 -/- (leu/Leu)
GPX1 +/- (Pro/Leu)
GPX1 +/+ (Pro/Pro)
(reference)
SOD2 -/- (Val/Val)
SOD2 +/- (Ala/Val)
SOD2 +/+ (Ala/Ala)
(reference)
Age
Non-Hispanic (reference)
Hispanic
White (reference)
Black
Asian
Native American
Years at Factory
Alcoholic Drinks per
Week×Yrs.
Cigarette Pack×Years
Noise Exposure Index
Recreational noise protection
Solvent Exposure Group
Years × Solvent Exposure
Group
Acute Solvent Intoxication
Hair Color Black (reference)
Hair Color Blond
Hair Color Auburn
Hair Color Brown
Eye Color Brown (reference)
Eye Color Blue
Eye Color Green
Eye Color Other

Multivariate Models

β

P value

-0.2

0.87

-0.73
0.61

0.71
0.66

3.0
1.3

0.17
0.31

0.33
-1.3

0.86
0.44

-0.27

<.0001

1.15

0.4

0.9
7.68
1.8
-0.2
-0.006

0.67
0.02
0.74
0.03
0.31

-0.08
-0.02
-0.01
-0.9
-0.06

0.19
0.32
0.17
0.24
0.05

-1.82

0.41

-1.9
2.3
1.1

-0.33
0.26
0.57

-4.3
-1.3
1.39

0.04
0.60
0.55

Age ≤ 43

All Ages
β

P value

β

P value

-0.25

<0.0001

-0.48

0.0009

0.70

0.0074

43 < Age
β

P value
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This protective association between the SOD2 genotypes with at least one valine allele
was also seen in the model composed of subjects older than 43 years (β = -18.95 and β =
-26.42 for SOD2 Val/Val and Val/Ala respectively), although only the heterozygous
genotype association demonstrated significance (p-value .026).
The GSTP1 Val/Ile at position 105 genotype demonstrated an adjusted regression
coefficient suggesting an association as a risk factor for worse high-frequency PTA (β =
12.41 p-value 0.01. No model showed an association of GSTM status with PTA
outcome.
Within the model of the older individuals, the GPX1 Leu/Leu at position 198 genotype
demonstrated a powerful protective association for high frequency PTA with β = -47.81
(p-value 0.03). A less pronounced protective coefficient was observed with the GPX1
Pro/Leu genotype (β= -8.23), but the association did not demonstrate statistical
significance with a p-value of 0.24. The same trend was observed in the bivariate
analysis for GPX Pro105Leu allele with a β = -16.19 for Leu/Leu (P value = 0.02) and β
= 10.0 for Pro/Leu (P value = 0.01).
Within the younger multivariate model, age, race, years at the factory, noise exposure
index, and alcohol use also correlated with PTA thresholds in a statistically significant
way. Within the older group model race, years at factory, solvent exposure group, years
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× solvent exposure group index, and eye color also showed significant association with
PTA outcome.

Distortion Products Otoacoustic Emissions
The models constructed with binaural averages of the distortion product otoacoustic
emissions at 3, 4, and 6 kHz are summarized in table 3. Bivariate modeling showed
DPOAEs were also significantly negatively associated with age (lower DPOAE values
reflect worse hearing status) β = -0.27 (P value = <0.0001) along with years at the factory
β = -0.2 (P value = 0.03), and the related solvent group time index β=-0.06 (P value =
0.05). A powerful protective effect of being of Asian race on DPOAEs was also
observed with β= 7.68 (P value 0.02). Given the powerful negative effect of age
observed in bivariate analysis in the tested outcomes, we stratified the study group into
those at and above and below the median age of 44 for multivariate model analysis in
hopes of detecting variables that might have a lesser but significant effect on the
outcomes.
As a group, the multivariate model analysis showed a highly significant negative effect of
age on the measured emissions in the entire study group with a β value = -0.25 and pvalue = <0.0001 in the all ages multivariate model. The effect of age on the DPOAEs is
more pronounced when modeled in the younger age group with β value = -0.48 and pvalue = 0.0009. A similar effect of age was detected in the bivariate analysis. This
model also showed an effect of years at the factory as having a positive effect on
DPOAEs with a β value = 0.70 and p-value = 0.0074. No effect was observed in the
model composed of the age > 43 group.

30

Very High Frequency PTA Thresholds and Dichotic Digits
Genetic markers did not demonstrate an effect on very high frequency hearing thresholds
(12-26 kHz) in the study group with only the covariates age (β value = 1.81 and p-value =
< 0.0001) and solvent group (β value = 8.80 and p-value = 0.047) being significantly
associated with worse thresholds. The dichotic digits model only showed a (negative)
effect of solvent group on test scores (β value = -1.10 and p-value = 0.0004).

DISCUSSION
The analysis revealed that several of the antioxidant gene polymorphisms were associated
with significantly better or worse hearing outcomes. Interestingly, no single
polymorphism showed a significant effect across all age groups and outcomes. However,
significant associations were observed between improved PTA thresholds and the SOD2
Ala/Val genotype in both groups of the age stratified models. The SOD Val/Val genotype
showed a similar association with the correlation reaching statistical significance in the
younger age group and approaching significance in the older group. These results suggest
that some antioxidant genotypes may modify susceptibility to sensorineural hearing loss.
This study is subject to limitations. Though that analysis yielded statistically significant
associations of several exposure variables with hearing outcome, the sample size
engenders statistical power probably most suitable for a pilot study. It is also worth
noting that a relatively large number of models were constructed and tested. The design
as a cross-sectional observational cohort only provides data at the time of collection with
no measurement of workers hearing status over time with no collection of preemployment hearing status. Noise, though not measured to such a level within the
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factory that would require a hearing conservation program, could be heterogeneously
distributed among working spaces in the factory and some workers could have been more
exposed than others effecting hearing status in a subset of subjects. Also, efforts to
characterize noise and ototoxic exposures that were unrelated to the occupational setting
were dependent upon questionnaire answers; this presents a challenge in terms of
quantifying exposure levels. Additionally, data collected by questionnaire relating to past
exposures to noise, solvents, and other ototoxic agents is also subject to general recall
bias. This study population was also particularly prone to confounding affects due to
cigarette smoking and alcohol use.
The association of GSTP1 status and PTA outcomes showed an interesting protective
effect of having the heterozygous Ile/Val genotype. The above-mentioned change in
substrate specificity in the GSTP1 Ile105Val variant may in part explain the observed
heterozygous disadvantage in regards to high frequency pure tone thresholds. It is
possible that the change in the enzyme’s heat stability and substrate preference
significantly impacts the enzyme’s ability to protect the cochlear tissues from solvent
mediated damage when there is at least one copy of the Val expressing allele. The
reasons for a lack of more dramatically elevated thresholds in the subjects expressing
Val/Val are unclear. The lack of correlation of elevated threshold and Val/Val
homozygotes could simply relate to the small number of individuals in the cohort that had
a Val/Val genotype (12 (14%)); this observation could also be due to the more
pronounced deficit stimulating a compensatory pathway.
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Within the older age group there was also a significant observed association of the GPX1
Leu/Leu genotype and favorable hearing thresholds. The level of the Leu expressing
variant of this allele has been shown experimentally to be less inducible in response to
selenium supplementation99. This variant has, however, not been shown to demonstrate
an inherent decreased enzymatic activity. Further analysis is needed to mechanistically
explain the observed association of this Leu allele with more favorable hearing
thresholds.
The lack of association between any of the polymorphisms analyzed and the measured
distortion product otoacoustic emissions is difficult to explain given the significant
findings for the same SNPs associations with hearing thresholds. Otoacoustic emissions
are generated by the outermost hair cells; it is possible that the pathway for the generation
of the OAEs is differentially sensitive to solvents and/or oxidative stress compared to the
tissue and pathway measured with hearing threshold values; indeed DPOAEs have been
studied as a more sensitive indicator of hearing loss109, 110. It is true that a large
proportion of the older workers in our set had undetectable DPOAEs (only 5 (12.5%) of
subjects had detectible DPOAE’s in the 44-67 age group), making detection of any effect
less probable with the analysis. However, age overall did have its predicted effect on
DPOAEs and PTA thresholds rendering the results of this analysis that were observed
more plausible.
The lack of effect of any of the antioxidant SNPs on the dichotic digits test could be due
to the nature of the test being designed to preferentially detect defects in central auditory
processing rather than peripheral hearing loss. Also many of the study participants were
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Spanish speaking and the test is administered using English spoken numbers and it is the
suspicion of the author that spoken language confounded the results.
Perhaps the most striking finding in this study lies in the observed relationship of the
SOD2 genotype with high frequency audiometric thresholds. In the age stratified
multivariate model adjusting for the effects of age, race, noise and solvents in the cohort
of workers, subjects that possessed a valine containing genotype at position 16
demonstrated superior high frequency pure tone audiometric thresholds compared to
subjects expressing only alanine at the same position; this association was demonstrated
in a statistically significant dose dependant fashion in the younger age group.
It is difficult to interpret epidemiological studies in light of results of laboratory
investigation of the transport and functionality of the SOD2 Val-16 and Ala-16 allotypes
here considered. One would expect the more functional and efficiently transported
alanine variant of SOD2 to be associated with superior hearing status when compared to
the less functional valine variant. It should be noted that the studies conducted by Sutton
et al. into the transport and functionality of the SOD2 variants were conducted in rat and
human liver cells and may not be entirely translatable to cochlear cells 77. Indeed,
discordant reports of disease associations have posed a challenge for proposing
mechanisms for MnSOD modification of risk in disease74, 75, 78-80, 82-84, 86. It is important
to recognize that antioxidant enzymes work in balanced concert to detoxify reactive
oxygen species. MnSOD catalyzes the conversion of O2 - into H2O2, which is itself
another reactive species that requires conversion to inert species largely via the Catalase
and GPX enzymes. It has been shown experimentally in vitro and in vivo that increasing
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concentration of Cu/ZnSOD111 and MnSOD112 had a bell-shaped curve in relationship to
exacerbation and protection of post-hypoxic tissue from reperfusion oxidative damage.
Michiels et al. postulated that this observed effect may be due to imbalance between
Catalase and SOD enzymes resulting in unfavorable concentrations of O2 - and H202
resulting in formation of highly reactive Hydroxyl radicals via the Haber-Weiss
reaction113.

McCord et al. explain the apparent hormetic nature of oxidative protection

curves from increasing SOD activity by suggesting that lipid peroxidation resultant from
oxidative damage is both initiated and terminated by O2-114; They conclude that the
absolute reduction in the amount of O2- brought about by increased SOD would eliminate
an important means of controlling the level of lipid peroxidation in cells under oxidative
stress.114 Additionally, it may be that in some tissues the level of H2O2 generated by the
alanine variant is more damaging in the hearing tissues than the O 2- it is produced from
by the action of SOD2 within the mitochondria; this may be via the generation of
hydroxyl radicals or by some other mechanism.
There are other means by which the Ala allele could possibly contribute to hearing loss;
Associations of both alleles at this locus are appearing in the literature with regularity. It
is very feasible that SOD2 is involved in a number of differing mechanisms leading to
disease. For example, Kakko et al. demonstrated a small but significant association
between the Ala allele and the degree of atherosclerosis in a Finnish cohort 115, given this
report it is conceivable that this allele’s effect on the cochlea could be of purely
potentiating the probability of sustaining a vascular insult.

35

It is also possible, and even likely, that the genetic relationship of the SOD2
polymorphism Ala16Val is more complex than the results suggest, this is often true of
single nucleotide polymorphisms116, 117. Linkage disequilibrium between the valine
containing alleles and another variation that either increases risk of hearing loss with
solvent, age, or noise exposure, or independently, cannot be ruled out as an explanation
of this observed pattern.
The findings of this study provide additional support for the hypothesis that antioxidant
genes play a role in the pathogenesis of hearing loss and provide the first evidence to
suggest known functional single nucleotide polymorphisms may specifically modify risk
in solvent-induced hearing loss. Our findings should encourage additional investigation
into the relationship of antioxidant gene SNPs with hearing loss in solvent exposed
workers.
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TABLE LEGEND
Table 1. Variables used in construction of the statistical regression models that were
collected by participant questionnaire and genetic analysis of antioxidant gene
polymorphisms.
Table 2. Statistically significant results from bivariate and multivariate analysis of
variables with pure tone audiometry thresholds (average of both ears at 3, 4, 6 kHz) as the
outcome. Higher Threshold values represent worse hearing status. The multivariate
analyses include the entire data set and two models composed of age groups above and
below ( age ≤ 43 and 43<age) the mean age for the study group.
Table 3. Statistically significant results from bivariate and multivariate analysis of
variables with distortion product otoacoustic emissions as outcome (average of both ears
at 3, 4, 6 kHz). Higher DPOAE values represent better hearing status. The multivariate
analyses include the entire data set and two models composed of age groups above and
below ( age ≤ 43 and 43<age) the mean age for the study group.

